Provided by Tiger Fintech (Singapore) Pte. Ltd.

Creative Medical Technology Holdings, Inc.

2.00
-0.0399-1.96%
Volume:7.96K
Turnover:15.99K
Market Cap:5.17M
PE:-0.53
High:2.02
Open:2.02
Low:2.00
Close:2.04
Loading ...

Creative Medical Technology Holdings Inc expected to post a loss of 40 cents a share - Earnings Preview

Reuters
·
10 May

Creative Medical Technology Holdings Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
10 May

Creative Medical Technology Holdings Inc. Conducted Special Stockholder Meeting

Reuters
·
07 May

Creative Medical Technology Holdings Inc expected to post a loss of 52 cents a share - Earnings Preview

Reuters
·
07 May

Creative Medical Technology files to sell 1.8M shares of common for holders

TIPRANKS
·
03 Apr

Creative Medical Technology price target lowered to $26 from $30 at Roth MKM

TIPRANKS
·
21 Mar

Creative Medical Technology Holdings Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
21 Mar

Creative Medical Receives FDA Approval to Expand Dosing in Back Pain Trial

MT Newswires Live
·
20 Mar

Creative Medical secures FDA clearance for dose escalation in Phase 1/2 trial

TIPRANKS
·
20 Mar

Creative Medical Technology Holdings Secures FDA Clearance for Expanded Dose Escalation in the Clinical Trial of Celz-201-Ddt for Chronic Lower Back Pain

THOMSON REUTERS
·
20 Mar

Creative Medical Technology Holdings Inc expected to post a loss of 64 cents a share - Earnings Preview

Reuters
·
19 Mar

Creative Medical Technology Holdings, Inc.'s (NASDAQ:CELZ) Shift From Loss To Profit

Simply Wall St.
·
16 Mar

Creative Medical announces agreements for exercise of warrants

TIPRANKS
·
06 Mar

Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $3.7 Million Gross Proceeds

THOMSON REUTERS
·
06 Mar

Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $3.7 Million Gross Proceeds

GlobeNewswire
·
06 Mar

BUZZ-Creative Medical Technology rises on positive data for stem cell therapy

Reuters
·
14 Feb

Creative Medical Technology Holdings Announces Mid-Term Follow-up Study Data Reporting Significant Reduction in Opioid Use by Chronic Lower Back Pain Patients Undergoing Stemspine® Procedure Using Allostem™

THOMSON REUTERS
·
14 Feb

Creative Medical Technology Holdings Announces Mid-Term Follow-up Study Data Reporting Significant Reduction in Opioid Use by Chronic Lower Back Pain Patients Undergoing StemSpine® Procedure using AlloStem™

GlobeNewswire
·
14 Feb

Creative Medical Technology reports one-year results for AlloStem program

TIPRANKS
·
11 Feb

Creative Medical Technology Holdings Inc - Announces Promising One-Year Data From Allostem Type 2 Diabetes Study

THOMSON REUTERS
·
11 Feb